Navigation Links
Duska Therapeutics Applies for Phase 3 Special Protocol Assessment
Date:11/20/2008

ous injection, is an investigational drug for the acute termination of PSVT. The bradycardic effect of ATP, in particular its blockade of atrio-ventricular (AV) nodal conduction, has been shown in multiple published clinical studies to safely and effectively terminate re-entrant PSVT involving the AV node. Injectable formulations of ATP, similar to ATPace, have been approved and marketed in Europe as pharmaceuticals for over 50 years as safe and efficacious treatments for PSVT.

Currently, adenosine is the only approved treatment for PSVT in the United States. Duska believes that the initial dose of ATPace will be significantly more efficacious than the initial labeled dose of adenosine in terminating PSVT. While both ATP and adenosine inhibit AV nodal conduction, ATP is believed to have dual inhibitory action, one mediated by adenosine, the product of its ATP's rapid enzymatic degradation, and the other a triggered vagal reflex. Vagal maneuvers, such as Valsalva maneuvers, aimed at enhancing vagal tone to the heart, and thereby suppressing atrio-ventricular nodal conduction, have been clinically used to terminate tachycardia in certain cases.

"The request for a SPA represents a significant milestone in the development of ATPace," stated James S. Kuo, MD, MBA, Duska's chief executive officer. "We believe that the Phase 3 clinical trial with ATPace should demonstrate the safety and efficacy of our drug in PSVT," he added.

About Duska (http://www.duskatherapeutics.com):

Duska is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiova
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
2. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
3. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
4. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
5. InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer
6. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
7. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
8. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
9. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
10. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
11. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... Research and Markets has announced the addition ... report to their offering. Multiple ... in demyelination, axonal transection, and neurodegeneration. The myelin sheath ... immune system, which targets neurons within the central nervous ... which the damage of the myelin sheath causes disruption ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... CHATTANOOGA, Tenn., Feb. 28, 2011 Glenveigh Medical, LLC ... exclusive distribution rights in the United States as well ... AN24 wireless fetal monitoring system. The system recently received ... Marketed under the trade name Beacon by Monica™ ...
... Bacterin International Holdings, Inc. ("Bacterin") (OTC Bulletin Board: ... material, today announced that its recently launched OsteoSponge®SC, a ... used by a high volume orthopedic institution, Arkansas Surgical ... in N Little Rock, AR, opened in 2005, is ...
Cached Medicine Technology:Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System 2Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC 2Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC 3
(Date:8/29/2014)... August 30, 2014 Developed as a ... high quality Canada Goose products offer the ... working on Arctic runways. The company’s Canada Goose ... in the current market. Additionally, the firm has unveiled ... offer. , At present, all high quality Chilliwack ...
(Date:8/29/2014)... According to a CNN article, entitled ... (8/25), a new study found that those states who ... a significant decrease in the number of painkiller overdoses ... year period, and comparing various states with and without ... there was about a 25% decrease in painkiller prescription ...
(Date:8/29/2014)... As reported by CNN.com in the article Prescription ... admitting that you need help for a prescription drug abuse ... the fact that if you simply try to find general ... all of the information that is available online. Although the ... is still possible to get help. The statistics from SAMSHA ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... article entitled How Genes, Gender and Environment Influence Substance ... gender and the environment that an individual is in affect ... Indiana University are taking another look at the fact that ... this factor to what is known about the influences of ... ties can help to reduce a man’s risk for abusing ...
Breaking Medicine News(10 mins):Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 2Health News:Overdoses on Painkillers Decreased in States With Medical Marijuana 3Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 2Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 3
... converging in patient care at a faster pace than ... point-of-care health technologies like telemedicine to medical robots performing ... What,s next? Ask NJIT Distinguished Professor Atam Dhawan, ... Albert Dorman Honors College, chair of the the ...
... is available in German . Protein deposits in ... alteration of the tau protein through the addition of phosphate groups ... the cells to aggregate into clumps. As a result, nerve cells ... plays an important role in learning and memory, as well as ...
... EAST LANSING, Mich. For the first time, ... for migraine sufferers, a finding that could help ... ailment. Jie Huang of Michigan State ... imaging, or fMRI, to reveal how precision-tinted lenses ...
... , THURSDAY, May 26 (HealthDay News) -- College ... are bigger and faster than the rest, according to new ... of the Journal of Strength and Conditioning Research , ... players who were "highly recruited" by college scouts were height, ...
... 26, 2011Young adults ages 19-29 are struggling to get the ... group, demonstrating the need for Affordable Care Act provisions, some ... it more affordable, according to a new Commonwealth Fund report. ... adults couldn,t afford the care they needed, meaning they didn,t ...
... of researching traumatic stress with war-afflicted populations (veterans and ... McIntyre, a research professor in the department of psychology ... (TIMES), at the University of Houston (UH), decided to ... seventh and eighth grade. "Teaching is a ...
Cached Medicine News:Health News:5 new hot spots where medicine and technology will converge 2Health News:Stress may increase risk for Alzheimer's disease 2Health News:Precision-tinted lenses offer real migraine relief, reveals new study 2Health News:Speed, Size Predict Teen Football Players' Rankings 2Health News:Health reform essential to young adults: Nearly half can't afford needed health care 2Health News:Health reform essential to young adults: Nearly half can't afford needed health care 3Health News:Health reform essential to young adults: Nearly half can't afford needed health care 4Health News:New University of Houston research study links job stress in teachers to student achievement 2Health News:New University of Houston research study links job stress in teachers to student achievement 3
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes....
... Application: Pipette tips in a ... Product features of Autoclavable Racks: ... C, Tips supplied in racks with ... Each row of tips is specifically ...
RNase-free Tips...
Medicine Products: